Pathophysiologic and Transcriptomic Analyses of Viscerotropic Yellow Fever in a Rhesus Macaque Model
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathophysiologic and Transcriptomic Analyses of Viscerotropic Yellow Fever in a Rhesus Macaque Model
Authors
Keywords
-
Journal
PLoS Neglected Tropical Diseases
Volume 8, Issue 11, Pages e3295
Publisher
Public Library of Science (PLoS)
Online
2014-11-21
DOI
10.1371/journal.pntd.0003295
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intrinsic T- and B-cell defects impair T-cell-dependent antibody responses in mice lacking the actin-bundling protein L-plastin
- (2013) Elizabeth M. Todd et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interfering with coinhibitory molecules: BTLA/HVEM as new targets to enhance anti-tumor immunity
- (2013) Christine Pasero et al. IMMUNOLOGY LETTERS
- Immunity and immune response, pathology and pathologic changes: progress and challenges in the immunopathology of yellow fever
- (2013) Juarez A. S. Quaresma et al. REVIEWS IN MEDICAL VIROLOGY
- Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease
- (2013) Ananda S. Prasad Advances in Nutrition
- Vaccines for viral hemorrhagic fevers—progress and shortcomings
- (2013) Darryl Falzarano et al. Current Opinion in Virology
- Pathogenesis of the Viral Hemorrhagic Fevers
- (2012) Slobodan Paessler et al. Annual Review of Pathology-Mechanisms of Disease
- Review of the risks and benefits of yellow fever vaccination including some new analyses
- (2012) Thomas P Monath Expert Review of Vaccines
- Increased Viral Loads and Exacerbated Innate Host Responses in Aged Macaques Infected with the 2009 Pandemic H1N1 Influenza A Virus
- (2012) L. Josset et al. JOURNAL OF VIROLOGY
- A Flow Cytometry-Based Assay for Quantifying Non-Plaque Forming Strains of Yellow Fever Virus
- (2012) Erika Hammarlund et al. PLoS One
- A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain
- (2012) Brett A. Thibodeaux et al. VACCINE
- Yellow fever outbreak affecting Alouatta populations in southern Brazil (Rio Grande do Sul State), 2008-2009
- (2011) Marco Antônio Barreto de Almeida et al. AMERICAN JOURNAL OF PRIMATOLOGY
- The Actin-Bundling Protein L-Plastin Is Essential for Marginal Zone B Cell Development
- (2011) E. M. Todd et al. JOURNAL OF IMMUNOLOGY
- Viperin, a key player in the antiviral response
- (2011) Sandy Mattijssen et al. MICROBES AND INFECTION
- Differential cytokine responses from primary human Kupffer cells following infection with wild-type or vaccine strain yellow fever virus
- (2011) Sara E. Woodson et al. VIROLOGY
- Alterations in the Aedes aegypti Transcriptome during Infection with West Nile, Dengue and Yellow Fever Viruses
- (2011) Tonya M. Colpitts et al. PLoS Pathogens
- Yellow Fever: A Reemerging Threat
- (2010) Christina L. Gardner et al. CLINICS IN LABORATORY MEDICINE
- Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis
- (2010) Nadia Wauquier et al. PLoS Neglected Tropical Diseases
- Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
- (2008) Denis Gaucher et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Case of Yellow Fever Vaccine–Associated Viscerotropic Disease with Prolonged Viremia, Robust Adaptive Immune Responses, and Polymorphisms in CCR5 and RANTES Genes
- (2008) Bali Pulendran et al. JOURNAL OF INFECTIOUS DISEASES
- Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
- (2008) Troy D Querec et al. NATURE IMMUNOLOGY
- Adverse event reports following yellow fever vaccination
- (2008) Nicole P. Lindsey et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started